Defibrillation testing at the time of ICD insertion: An analysis from the Ontario ICD registry

Journal of Cardiovascular Electrophysiology

Volumn 21, Issue 12, 2010, Pages 1344-1348

  Healey, J S ^a   Birnie, D H ^b   Lee, D S ^c,h   Krahn, A D ^d   Crystal, E ^e   Simpson, C S ^f   Dorian, P ^g   Chen, Z ^c   Cameron, D ^h   Verma, A ⁱ   Connolly, S J ^a   Gula, L J ^d   Lockwood, E ^j   Nair, G ^a   Tu, J V ^c,e  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^c INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^d UNIVERSITY OF WESTERN ONTARIO   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

^f QUEEN S UNIVERSITY   (Canada)

^g ST MICHAEL'S HOSPITAL   (Canada)

^h UNIVERSITY HEALTH NETWORK   (Canada)

ⁱ SOUTHLAKE REGIONAL HEALTH CENTRE   (Canada)

^j ROYAL ALEXANDRA HOSPITAL   (Canada)

more..

Author keywords

atrial fibrillation; complications; heart failure; implantable cardioverter defibrillator; registry; sudden death; ventricular tachycardia

Indexed keywords

AMIODARONE;

ADULT; ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DEFIBRILLATION; DEFIBRILLATOR; DEMOGRAPHY; FEMALE; HEART FAILURE; HEART TAMPONADE; HEMATOMA; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; PATIENT SELECTION; PHYSICIAN; PNEUMOTHORAX; PRIORITY JOURNAL; RATING SCALE; REGISTER; STROKE; WOUND HEMORRHAGE;

AGED; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; FEMALE; HUMANS; MALE; MIDDLE AGED; MONITORING, INTRAOPERATIVE; ONTARIO; PROSPECTIVE STUDIES; REGISTRIES; TIME FACTORS;

EID: 78650126085     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2010.01850.x     Document Type: Article

References (19)

1. Curtis AB,: Defibrillation threshold testing in implantable cardioverter-defibrillators: Might less be more than enough? J Am Coll Cardiol 2008; 52: 577-578.
2. Strickberger SA, Klein GJ,: Is defibrillation testing required for defibrillator implantation. J Am Coll Cardiol 2004; 44: 88-91.
3. Swerdlow CD, Shehata M, Chen PS,: The dilemma of ICD implant testing. Pacing Clin Electrophysiol 2007; 30: 258-270.
4. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH,; Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators: Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005; 352: 225-237.
5. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML,: Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346: 877-883.
6. Gold MR, Higgins S, Klein R, Gilliam FR, Kopelman H, Hessen S, Payne J, Strickberger SA, Breiter D, Hahn S,: Efficacy and temporal stability of reduced safety margins for ventricular defibrillation: Primary results from the Low Energy Safety Study (LESS). Circulation 2002; 105: 2043-2048.
7. Russo AM, Sauer W, Gerstenfeld EP, Hsia HH, Lin D, Cooper JM, Dixit S, Verdino RJ, Nayak HM, Callans DJ, Patel V, Marchlinski FE,: Defibrillation threshold testing: Is it really necessary at the time of implantable cardioverter-defibrillator insertion? Heart Rhythm 2005; 2: 456-461.
8. Pires LA, Johnson KM,: Intraoperative testing of the implantable cardioverter defibrillator: How much is enough? J Cardiovasc Electrophysiol 2006; 17: 140-145.
9. Blatt JA, Poole JE, Johnson G, Callans DJ, Raitt MH, Reddy RK, Marchklinski FE, Yee R, Guarnieri T, Talajic M, Wilber DJ, Anderson J, Chung K, Wong WS, Mark DB, Lee KL, Bardy GH,; SCD-HeFT Investigators: No benefit from defibrillation threshold testing in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial). J Am Coll Cardiol 2008; 52: 551-556.
10. Christ G, Becker R, Voss F, Kelemen K, Senges-Becker J, Hauck M, Schoels W, Bald I, Katus HA, Bauer A,: Idications for predismissal testing with arrhythmia-inducation in patients receiving an implantable cardioverter defibrillator. Clin Res Cardiol 2007; 96: 613-620.
11. Birnie D, Tung S, Simpson C, Crystal E, Exner D, Ayala-Paredes FA, Krahn A, Parkash R, Khaykin Y, Philippon F, Guerra P, Kimber S, Cameron D, Healey JS,: Complications associated with defibrillation threshold testing: The Canadian experience. Heart Rhythm 2008; 5: 387-390.
12. Brignole M, Raciti G, Bongiorni MG, De Martino G, Favale S, Gasparini M, Luise R, Occhetta E, Proclemer A,: Defibrillation testing at the time of implantation of cardioverter defibrillator in the clinical practice: A nation-wide survey. Europace 2007; 9: 540-543.
13. Healey JS, Dorian P, Mitchell LB, Talajic M, Philippon F, Simpson C, Yee R, Morillo CA, Lamy A, Basta M, Birnie DH, Wang X, Nair GM, Crystal E, Kerr CR, Connolly,: Canadian Registry of ICD Implant Testing Procedures (CREDIT): Current practice, risks and costs of intraoperative defibrillation testing. J Cardiovasc Electrophysiol 2010; 21: 177-182.
14. Lee DS, Birinie D, Cameron D, Crystal E, Dorian P, Gula LJ, Healey JS, Janmohammed A, Khaykin Y, Krahn AD, LeFeuvre C, Simpson CS, Yee R, Hardy J, Slaughter PM, Chen Z, Alter DA, Laupacis A, Tu JV,: Design and implementation of a population-based registry of implantable cardioverter defibrillators (ICDs) in Ontario. Heart Rhythm 2008; 5: 1250-1256.
15. Lee DS, Krahn AD, Healey JS, Birnie D, Crystal E, Dorian P, Simpson CS, Khaykin Y, Cameron D, Janmohamed A, Yee R, Austin PC, Chen Z, Hardy J, Tu JV,; Investigators of the Ontario ICD Database: Evaluation of early complications related to de novo cardioverter defibrillator implantation: Insights from the Ontario ICD database. J Am Coll Cardiol 2010; 55: 774-782.
16. Leong-Sit P, Gula LJ, Diamantouoros P, Krahn AD, Skanes AC, Yee R, Klein GJ,: Effect of defibrillation testing on management during implantable cardioverter-defibrillator implantation. Am Heart J 2006; 152: 1104-1108.
17. Hohnloser SH, Dorian P, Roberts RS, Gent M, Israel CW, Fain E, Champagne J, Connolly SJ,: Effect of amiodarone and sotalol on ventricular defibrillation threshold: The optimal pharmacological therapy in cardioverter defibrillator patients (OPTIC) trial. Circulation 2006; 114: 104-109.
18. Connolly SJ, Dorian P, Roberts RS, Gent M, Bailin S, Fain ES, Thorpe K, Champagne J, Talajic M, Coutu B, Gronefeld G, Hohnloser SH,: Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: The OPTIC Study: A randomized trial. JAMA 2006; 295: 165-171.
19. Healey JS, Hohnloser SH, Glikson M, Neuzner G, Kautzner J, Gadler F, Mabo P, Vinolas X, Van Erven L, Connolly SJ,: A novel design for a randomized trial to test if ICD implantation without any defibrillation testing is as effective as standard treatment. Heart Rhythm 2009; 6: S374.